Linked Life Data

citation

Source:http://linkedlifedata.com/resource/drugbank/citation/citation

Statements in which the resource exists.
SubjectPredicateObjectContext
literatureCitation:587_1003...literatureCitation:citation Maingonnat C, Victor R, Bertrand P, Courel MN, Maunoury R, Delpech B: Activation and inhibition of human cancer cell hyaluronidase by proteins. Anal Biochem. 1999 Mar 1;268(1):30-4. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10036158 lld:drugbank
literatureCitation:587_1046...literatureCitation:citation Parameswaran S, Brown LV, Ibbott GS, Lai-Fook SJ: Effect of concentration and hyaluronidase on albumin diffusion across rabbit mesentery. Microcirculation. 1999 Jun;6(2):117-26. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10466114lld:drugbank
literatureCitation:398_8415...literatureCitation:citation Begley JA, Colligan PD, Chu RC: Transcobalamin II mediated delivery of albumin-bound hydroxocobalamin to human liver cells. Proc Soc Exp Biol Med. 1993 Nov;204(2):206-10. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8415778 lld:drugbank
literatureCitation:398_5126...literatureCitation:citation Skouby AP, Hippe E, Olesen H: Antibody to transcobalamin II and B12 binding capacity in patients treated with hydroxocobalamin. Blood. 1971 Dec;38(6):769-74. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/5126165 lld:drugbank
literatureCitation:398_5488...literatureCitation:citation Hippe E, Olesen H, Skouby A: [Occurrence of antibodies against transcobalamin II in relation to the number of and the intervals between depot therapy with hydroxocobalamin] Nord Med. 1970 Dec 3;84(49):1570. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/5488577 lld:drugbank
literatureCitation:398_3338...literatureCitation:citation Brown KL, Marques HM, Jacobsen DW: Heteronuclear NMR studies of cobalamins. 31P NMR observations of cobalamins bound to a haptocorrin from chicken serum. J Biol Chem. 1988 Feb 5;263(4):1872-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/3338997 lld:drugbank
literatureCitation:398_8487...literatureCitation:citation Chu RC, Begley JA, Colligan PD, Hall CA: The methylcobalamin metabolism of cultured human fibroblasts. Metabolism. 1993 Mar;42(3):315-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8487649 lld:drugbank
literatureCitation:398_1458...literatureCitation:citation Seetharam B, Yammani RR: Cobalamin transport proteins and their cell-surface receptors. Expert Rev Mol Med. 2003 Jun 13;5(18):1-18. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/14585166lld:drugbank
literatureCitation:232_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:232_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3926_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:804_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:310_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:558_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:422_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:6_171392...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3983_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3986_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3990_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2339_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3992_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3982_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3984_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3985_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3971_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3995_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:3921_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2452_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:601_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2808_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2417_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2718_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:559_1713...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:2700_171...literatureCitation:citation Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 lld:drugbank
literatureCitation:232_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:232_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:310_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:558_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:422_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:6_170164...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3983_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3990_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2339_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3982_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3985_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3995_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:3921_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2452_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:601_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2808_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2417_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2718_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:559_1701...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:2700_170...literatureCitation:citation Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 lld:drugbank
literatureCitation:232_1175...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:587_1175...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:776_1175...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:558_1175...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:6020_117...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:3810_117...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:3939_117...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:3941_117...literatureCitation:citation Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11752352lld:drugbank
literatureCitation:1181_103...literatureCitation:citation Chu JS, Kishion S, Nomura A, Miyazaki K: Serum alpha 1-acid glycoprotein, sialic acid, and protein binding of disopyramide in normal subjects and cardiac patients. Zhongguo Yao Li Xue Bao. 1997 Sep;18(5):408-10. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10322928 lld:drugbank
literatureCitation:1181_108...literatureCitation:citation Hanada K, Ohta T, Hirai M, Arai M, Ogata H: Enantioselective binding of propranolol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein. J Pharm Sci. 2000 Jun;89(6):751-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10824133 lld:drugbank
literatureCitation:1181_146...literatureCitation:citation Nakagawa T, Kishino S, Itoh S, Sugawara M, Miyazaki K: Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants. Br J Clin Pharmacol. 2003 Dec;56(6):664-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/14616427 lld:drugbank
literatureCitation:1181_286...literatureCitation:citation Haughey DB, Steinberg I, Lee MH: Protein binding of disopyramide--displacement by mono-N-dealkyldisopyramide and variation with source of alpha-1-acid glycoprotein. J Pharm Pharmacol. 1985 Apr;37(4):285-8. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/2860235 lld:drugbank
literatureCitation:1181_286...literatureCitation:citation Brunner F, Muller WE: Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid. J Pharm Pharmacol. 1985 May;37(5):305-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/2862237lld:drugbank
literatureCitation:1680_109...literatureCitation:citation Stephenson KN, Croxen RL, El-Barbary A, Fenstermacher JD, Haspel HC: Inhibition of glucose transport and direct interactions with type 1 facilitative glucose transporter (GLUT-1) by etomidate, ketamine, and propofol: a comparison with barbiturates. Biochem Pharmacol. 2000 Sep 1;60(5):651-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10927023lld:drugbank
literatureCitation:232_7770...literatureCitation:citation Landyshev IuS, Grigorenko AA, Marikhina NS, Molochnaia SV: [A comparative assessment of the effect of different methods of glucocorticosteroid therapy on the hypophyseal-adrenal system in bronchial asthma patients] Ter Arkh. 1995;67(3):43-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/7770804 lld:drugbank
literatureCitation:587_1031...literatureCitation:citation Bratlid D, Bergan T: Displacement of albumin-bound antimicrobial agents by bilirubin. Pharmacology. 1976;14(5):464-72. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/1031216lld:drugbank
literatureCitation:587_1625...literatureCitation:citation Terasaki T, Nouda H, Tsuji A: Selective analysis of mutual displacement effects at the primary binding sites of phenoxymethylpenicillin and cephalothin bindings to human serum albumin. J Pharmacobiodyn. 1992 Mar;15(3):91-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/1625169lld:drugbank
literatureCitation:232_3996...literatureCitation:citation Groyer A, Le Bouc Y, Joab I, Radanyi C, Renoir JM, Robel P, Baulieu EE: Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor. Eur J Biochem. 1985 Jun 3;149(2):445-51. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/3996417 lld:drugbank
literatureCitation:232_7222...literatureCitation:citation Svec F, Harrison RW: Conditions affecting AtT-20 cell glucocorticoid uptake. Steroids. 1981 Feb;37(2):143-56. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/7222146 lld:drugbank
literatureCitation:232_7001...literatureCitation:citation Eisen HJ: An antiserum to the rat liver glucocorticoid receptor. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3893-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/7001446 lld:drugbank
literatureCitation:587_3521...literatureCitation:citation Pardridge WM: Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab. 1986 May;15(2):259-78. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/3521955lld:drugbank
literatureCitation:756_3521...literatureCitation:citation Pardridge WM: Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab. 1986 May;15(2):259-78. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/3521955lld:drugbank
literatureCitation:587_2867...literatureCitation:citation Aarons L, Khan AZ, Grennan DM, Alam-Siddiqi M: The binding of flurbiprofen to plasma proteins. J Pharm Pharmacol. 1985 Sep;37(9):644-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/2867185 lld:drugbank
literatureCitation:587_1686...literatureCitation:citation Takla PG, Schulman SG, Perrin JH: Measurement of flurbiprofen-human serum albumin interaction by fluorimetry. J Pharm Biomed Anal. 1985;3(1):41-50. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16867708lld:drugbank
literatureCitation:587_1611...literatureCitation:citation Port M, Corot C, Violas X, Robert P, Raynal I, Gagneur G: How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol. 2005 Sep;40(9):565-73. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16118549 lld:drugbank
literatureCitation:587_9055...literatureCitation:citation Wendland MF, Saeed M, Lauerma K, Derugin N, Mintorovitch J, Cavagna FM, Higgins CB: Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med. 1997 Mar;37(3):448-56. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/9055236 lld:drugbank
literatureCitation:587_9406...literatureCitation:citation Cavagna FM, Maggioni F, Castelli PM, Dapra M, Imperatori LG, Lorusso V, Jenkins BG: Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997 Dec;32(12):780-96. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/9406019 lld:drugbank
literatureCitation:587_1608...literatureCitation:citation Chang-Ying Y, An-Xin H, Yi L, Hui T, Song-Sheng Q: Some properties of the interaction between 2,2'-diselenadibenzoic acid and serum albumins. J Pharm Biomed Anal. 2005 Sep 1;39(1-2):263-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16085141 lld:drugbank
literatureCitation:587_1625...literatureCitation:citation Choi EJ, Foster MD: Surfactant displacement of human serum albumin adsorbed on loosely packed self-assembled monolayers: cetyltrimethylammonium bromide versus sodium dodecyl sulfate. J Colloid Interface Sci. 2003 May 15;261(2):273-82. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16256532 lld:drugbank
literatureCitation:587_1625...literatureCitation:citation Santos SF, Zanette D, Fischer H, Itri R: A systematic study of bovine serum albumin (BSA) and sodium dodecyl sulfate (SDS) interactions by surface tension and small angle X-ray scattering. J Colloid Interface Sci. 2003 Jun 15;262(2):400-8. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16256620 lld:drugbank
literatureCitation:587_1637...literatureCitation:citation Cao WG, Jiao QC, Liu Q: [Spatial orientation interaction mechanism of three component complex of protein--BSA/SDS/Azur a system] Guang Pu Xue Yu Guang Pu Fen Xi. 2005 Sep;25(9):1478-81. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16379295 lld:drugbank
literatureCitation:587_1645...literatureCitation:citation Schweitzer B, Felippe AC, Dal Bo A, Minatti E, Zanette D, Lopes A: Sodium dodecyl sulfate promoting a cooperative association process of sodium cholate with bovine serum albumin. J Colloid Interface Sci. 2006 Jun 1;298(1):457-66. Epub 2006 Feb 2. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16457837 lld:drugbank
literatureCitation:232_1063...literatureCitation:citation Emptoz-Bonneton A, Cousin P, Seguchi K, Avvakumov GV, Bully C, Hammond GL, Pugeat M: Novel human corticosteroid-binding globulin variant with low cortisol-binding affinity. J Clin Endocrinol Metab. 2000 Jan;85(1):361-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10634411 lld:drugbank
literatureCitation:232_1504...literatureCitation:citation Smith CL, Power SG, Hammond GL: A Leu----His substitution at residue 93 in human corticosteroid binding globulin results in reduced affinity for cortisol. J Steroid Biochem Mol Biol. 1992 Aug;42(7):671-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/1504007 lld:drugbank
literatureCitation:232_6800...literatureCitation:citation Frey BM, Frey FJ: Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion. Br J Clin Pharmacol. 1982 Feb;13(2):245-9. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/6800390 lld:drugbank
literatureCitation:232_7667...literatureCitation:citation Ko HC, Almon RR, Jusko WJ: Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats. Pharm Res. 1995 Jun;12(6):902-4. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/7667198 lld:drugbank
literatureCitation:232_5633...literatureCitation:citation Angeli A, Frajria R, De Paoli R, Fonzo D, Ceresa F: Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man. Clin Pharmacol Ther. 1978 Jan;23(1):47-53. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/563315 lld:drugbank
literatureCitation:566_1008...literatureCitation:citation Macdougall IC: Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999 Mar;69:S61-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10084288 lld:drugbank
literatureCitation:566_1157...literatureCitation:citation Salahudeen AK, Oliver B, Bower JD, Roberts LJ 2nd: Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int. 2001 Oct;60(4):1525-31. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11576368 lld:drugbank
literatureCitation:566_1731...literatureCitation:citation Pai AB, Boyd AV, McQuade CR, Harford A, Norenberg JP, Zager PG: Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. Pharmacotherapy. 2007 Mar;27(3):343-50. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17316146 lld:drugbank
literatureCitation:566_2208...literatureCitation:citation Jacobs JC, Alexander NM: Colorimetry and constant-potential coulometry determinations of transferrin-bound iron, total iron-binding capacity, and total iron in serum containing iron-dextran, with use of sodium dithionite and alumina columns. Clin Chem. 1990 Oct;36(10):1803-7. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/2208657 lld:drugbank
literatureCitation:566_2720...literatureCitation:citation Speyer BE, Doney VJ, Fielding J: Transfer of iron from Ferastral and other organic complexes to transferrin as measured by reticulocyte uptake. Scand J Haematol Suppl. 1977;32:215-21. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/272031lld:drugbank
literatureCitation:587_9275...literatureCitation:citation Bertucci C, Wainer IW: Improved chromatographic performance of a modified human albumin based stationary phase. Chirality. 1997;9(4):335-40. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/9275312 lld:drugbank
literatureCitation:587_1576...literatureCitation:citation Xiao HR, Sheng LQ, Shi CH, Xu XL, Xie YS, Liu QL: [Fluorescence study on the interaction of salicylic acid and bovine serum albumin] Guang Pu Xue Yu Guang Pu Fen Xi. 2004 Jan;24(1):78-81. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15768982 lld:drugbank
literatureCitation:587_1732...literatureCitation:citation Yin T, Wei W, Yang L, Liu K, Gao X: Kinetics parameter estimation for the binding process of salicylic acid to human serum albumin (HSA) with capacitive sensing technique. J Biochem Biophys Methods. 2007 Jun 10;70(4):587-93. Epub 2007 Jan 27. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17320187 lld:drugbank
literatureCitation:587_1581...literatureCitation:citation Yu T, Tao Z: [Fluorescence study on the interaction of salicylic acid and human serum albumin] Guang Pu Xue Yu Guang Pu Fen Xi. 1999 Jun;19(3):453-5. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15819089lld:drugbank
More...